We are pleased to announce that as of 16 August Zdravlje Pharmaceuticals (Bulgaria), a subsidiary of Zdravlje Leskovac, has received a Wholesale Distribution Authorization by the Bulgarian Drug Agency (BDA).

“This is an important step for both our Commercial and Contract Development and Manufacturing (CDMO) business lines as we are able to offer end-to-end solutions for our customers, including the import, test and release of goods in the EU”, said Kiren Naidoo, CEO of Zdravlje.